Compare MIR & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIR | CGC |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 401.0M |
| IPO Year | 2020 | 2023 |
| Metric | MIR | CGC |
|---|---|---|
| Price | $15.38 | $1.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $27.25 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 2.6M |
| Earning Date | 04-28-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | 84.17 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $23.95 | $8.27 |
| Revenue Next Year | $7.32 | $15.68 |
| P/E Ratio | $760.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.11 | $0.84 |
| 52 Week High | $30.28 | $2.38 |
| Indicator | MIR | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 65.68 |
| Support Level | $14.11 | $1.01 |
| Resistance Level | $20.29 | $1.08 |
| Average True Range (ATR) | 0.85 | 0.04 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 33.47 | 95.18 |
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.